Navigation Links
EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital

RICHMOND, Virginia and ROSH HA'AYIN, Israel, December 22 /PRNewswire/ -- EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $2.5 million. The round was led by Eli Gilboa, CPA, of Gilboa & Licht, who serves as the company's active chairman at a company valuation of US$18.5 million. To date, the company has raised a total US$10 million. Proceeds will be used to accelerate EnzySurge's sales and marketing efforts in the US during the first half of 2010. The addressable market for the DermaStream product line, global chronic wound care market, is estimated at close to US$4.0 billion annually.

EnzySurge recently announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its new SilverStream(TM) solution for prescription use. SilverStream is intended for use under the supervision of a healthcare professional for management and moisturizing of wounds such as stage I-IV pressure ulcers, stasis ulcers, diabetic foot ulcers, post-surgical wounds, first and second degree burns, cuts abrasions and minor skin irritations. The FDA also cleared the DermaSept, an Over-the-Counter version of the SilverStream product, which is intended for the management and moisturizing of minor cuts, minor burns, abrasions and irritated areas.

A single patient use disposable system, the DermaStream product line allows for the continuous streaming of fresh therapeutic solutions, such as the SilverStream solution, enzymatic debridement solutions and cleansing solutions, over the wound bed. The treatment provides constant removal of foreign material, exudate, micro-organisms and debris while creating negative pressure over the wound.

"I'm very pleased with this additional round of funding, says Amir Shiner, Chief Executive Officer. This financing allows us to execute our go-to-market market plan in the US during 2010. We recently completed a multi-center clinical study on venous ulcer patients. The preliminary study results demonstrate safety and preliminary efficacy of the DermaStream product line on venous ulcer patients and will strengthen the DermaStream clinical base of evidence that supports our growing marketing and sales activities in the US."

According to Mr. Shiner, the company operates its US marketing and sales activities from its office in Richmond, VA. "EnzySurge has been exploring strategic partnerships with a number of global wound care player," adds Shiner. "Such partnership may allow us to capitalize on the remarkable opportunities that have been recently opened for us in our markets."

    Contact Details :
    Amir Shiner
    Mobile : +972-54-3030294

    Eli Gilboa
    CHAIRMAN (Privet Placement Manager)
    Mobile : +972-54-4570011

SOURCE EnzySurge Ltd

SOURCE EnzySurge Ltd
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ACRIN Study Endorses Virtual Colonoscopy - Validation for Colon CAD Software Maker Medicsight plc
2. HealthCare Partners, IPA, Dr. Richard Merkin, CEO, Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington, DC
3. The Deal Names Abbott Top Dealmaker for Second Consecutive Year
4. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
5. Reportlinker Adds Cardiac Pacemakers - A World Market Analysis
6. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. GeoVax Secures $10 Million Financing Commitment
9. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
10. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
11. ALung Secures $2.5 Million
Post Your Comments:
(Date:11/30/2015)... , December 1, 2015 ... adds "Endometriosis - Pipeline Review, ... an overview on therapeutic pipeline of Endometriosis ... create effective counter strategies to gain competitive ... new targets and MOAs to produce first-in-class ...
(Date:11/30/2015)... 2015 ) ... Drugs Market 2015-2019" report to their offering. ... addition of the "Orphan Drugs Market 2015-2019" ... Research and Markets ( ) has announced ... 2015-2019" report to their offering. ...
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... Implant, the industry,s first MRI guided user interface and ... of patients with MR Conditional implants, such as knee ... 2015 Radiological Society of North America Annual Meeting ... and supports diagnostic confidence of this growing patient population. ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase awareness of the lack of standards ... inform dentists that the technicians they trust could lack the skills and knowledge ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... The directory is specialized and only includes chiropractic clinics in the US. , ... and trustworthy alternative health practitioner when back pain sets in. When people are ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... experience this summer, ushering in a new era of publicly accessible automated technology. ... shuttle, will continue to offer guests an up-close look at the shuttle at ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... for Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted ... featuring a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an effort ... to access life-saving information provided directly from top experts in mesothelioma, in ... individual conferences in three major cities: Houston, San Francisco, and Chicago. , ...
Breaking Medicine News(10 mins):